Results 11 to 20 of about 171,216,168 (330)

Business records of Standard Automobile Company of Wichita, Kansas

, 1910
This folder contains business records of Standard Automobile Company of Wichita, Kansas, dated between March 10, 1910 and January 1, 1911. There are requests for parts and autos, letters of complaint, and a letter from D. W.
Standard Automobile Company of Wichita, Kansas
core   +17 more sources

Business records of Standard Automobile Company of Wichita, Kansas

, 1909
This folder contains business records of Standard Automobile Company of Wichita, Kansas, dated between January 5, 1909 and December 23, 1909. There are requests for agency licenses, auto purchases, part requests and repairs.Archival master image scanned ...
Standard Automobile Company of Wichita, Kansas
core   +16 more sources

CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.

Canadian Journal of Cardiology, 2021
In this update of the Canadian Cardiovascular Society heart failure (HF) guidelines, we provide comprehensive recommendations and practical tips for the pharmacologic management of patients with HF with reduced ejection fraction (HFrEF).
M. McDonald, S. Virani, Michael C Chan, A. Ducharme, J. Ezekowitz, N. Giannetti, G. Heckman, J. Howlett, S. Koshman, S. Lepage, L. Mielniczuk, G. Moe, E. O’Meara, E. Swiggum, M. Toma, S. Zieroth, K. Anderson, Sharon A. Bray, B. Clarke, A. Cohen-Solal, M. D’Astous, Margot K. Davis, S. De, A. Grant, A. Grzeslo, J. Heshka, S. Keen, S. Kouz, Douglas S. Lee, F. Masoudi, R. McKelvie, Marie-Claude Parent, S. Poon, M. Rajda, Abhinav Sharma, Kyla Siatecki, K. Storm, B. Sussex, Harriette G. C. Van Spall, Amelia Yip   +39 more
semanticscholar   +1 more source

Multiple Myeloma in 2023 Ways: From Trials to Real Life

Current Oncology, 2023
Multiple myeloma is a chronic hematologic malignancy that obstinately tends to relapse. Basic research has made giant strides in better characterizing the molecular mechanisms of the disease.
Manlio Fazio, Vittorio Del Fabro, Nunziatina Laura Parrinello, Alessandro Allegra, Uroš Markovic, Cirino Botta, Fabrizio Accardi, Iolanda Donatella Vincelli, Salvatore Leotta, Federica Elia, Benedetta Esposito, Bruno Garibaldi, Gabriele Sapuppo, Alessandra Orofino, Alessandra Romano, Giuseppe A. Palumbo, Francesco Di Raimondo, Concetta Conticello   +17 more
doaj   +1 more source

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.

Journal of Clinical Oncology, 2020
PURPOSE Axicabtagene ciloleucel (axi-cel) is an autologous CD19-directed chimeric antigen receptor (CAR) T-cell therapy approved for relapsed/refractory large B-cell lymphoma (LBCL) on the basis of the single-arm phase II ZUMA-1 trial, which showed best ...
L. Nastoupil, M. Jain, Lei Feng, J. Spiegel, A. Ghobadi, Yi Lin, S. Dahiya, Matthew A. Lunning, L. Lekakis, P. Reagan, Olalekan O. Oluwole, J. McGuirk, A. Deol, A. Sehgal, A. Goy, Brian T. Hill, Khoan Vu, C. Andreadis, J. Muñoz, J. Westin, J. Chavez, A. Cashen, N. Bennani, A. Rapoport, J. Vose, David B. Miklos, S. Neelapu, F. Locke   +27 more
semanticscholar   +1 more source

Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?

Orphanet Journal of Rare Diseases, 2021
Background Pharmacological corticosteroid therapy is the standard of care in Duchenne Muscular Dystrophy (DMD) that aims to control symptoms and slow disease progression through potent anti-inflammatory action. However, a major concern is the significant
Stephanie Kourakis, Cara A. Timpani, D. Campelj, P. Hafner, N. Gueven, D. Fischer, E. Rybalka   +6 more
semanticscholar   +1 more source

Standard of care for lipedema in the United States

Phlebology, 2021
Background Lipedema is a loose connective tissue disease predominantly in women identified by increased nodular and fibrotic adipose tissue on the buttocks, hips and limbs that develops at times of hormone, weight and shape change including puberty ...
K. Herbst, Linda Anne Kahn, Emily Iker, C. Ehrlich, Thomas F Wright, L. McHutchison, Jaime S. Schwartz, Molly Sleigh, Paula M. C. Donahue, K. Lisson, Tami Faris, Janis M. Miller, Erik Lontok, Michael S. Schwartz, S. Dean, J. Bartholomew, P. Armour, M. Correa-Perez, N. Pennings, E. Wallace, E. Larson   +20 more
semanticscholar   +1 more source

Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of IDH1-Mutant Glioblastoma: An 80-Month Follow-Up Case Report

Frontiers in Nutrition, 2021
Background: Successful treatment of glioblastoma (GBM) remains futile despite decades of intense research. GBM is similar to most other malignant cancers in requiring glucose and glutamine for growth, regardless of histological or genetic heterogeneity ...
Thomas N. Seyfried, Aditya G. Shivane, Miriam Kalamian, Joseph C. Maroon, Purna Mukherjee, Giulio Zuccoli   +5 more
doaj   +1 more source

Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy

Orphanet Journal of Rare Diseases, 2022
Valosin-containing protein (VCP) associated multisystem proteinopathy (MSP) is a rare inherited disorder that may result in multisystem involvement of varying phenotypes including inclusion body myopathy, Paget’s disease of bone (PDB), frontotemporal ...
Manisha Korb, A. Peck, L. Alfano, K. Berger, M. James, N. Ghoshal, E. Healzer, C. Henchcliffe, Shaida Khan, P. Mammen, Sujata Patel, G. Pfeffer, S. Ralston, B. Roy, W. Seeley, A. Swenson, T. Mozaffar, C. Weihl, V. Kimonis, R. Fanganiello, Grace Lee, R. Mahoney, J. Diaz-Manera, T. Evangelista, M. Freimer, T. Lloyd, Benison Keung, H. Kushlaf, M. Milone, M. Needham, J. Palmio, T. Stojkovic, R. Villar-Quiles, Leo H. Wang, M. Wicklund, Frederick R. Singer, M. Jones, B. Miller, S. Sajjadi, A. Obenaus, M. Geschwind, A. Al-Chalabi, J. Wymer, Nita Chen, K. Kompoliti, Stephani C. Wang, Catherine Boissoneault, Betsaida Cruz-Coble, K. Garand, Anna J. Rinholen, Lauren Tabor-Gray, J. Rosenfeld, Ming Guo, N. Peck   +53 more
semanticscholar   +1 more source

Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC)

Current Oncology, 2023
To compare efficacy outcomes for all approved and investigational first-line (1L) treatment regimens for locally advanced or metastatic urothelial carcinoma (la/mUC) with standard of care (SOC), a network meta-analysis (NMA) was conducted.
Lisa Bloudek, Phoebe Wright, Caroline McKay, Christina Louise Derleth, Jennifer Susan Lill, Enrique Lenero, Zsolt Hepp, Scott David Ramsey, Sean D. Sullivan, Beth Devine   +9 more
doaj   +1 more source